- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Overactive Detrusor
Total 2023 results
-
Loyola UniversityKimberly-Clark CorporationCompletedOveractive Bladder | Nocturia | IncontinenceUnited States
-
Loma Linda UniversityCompletedOveractive Bladder | Menopause | CaffeineUnited States
-
Astellas Pharma IncCompleted
-
AllerganCompletedOveractive Bladder | Pharmacokinetics | ElderlyUnited States
-
Astellas Pharma Europe Ltd.Terminated
-
Boston Scientific CorporationCompletedOveractive BladderUnited States
-
GlaxoSmithKlineCompletedOveractive Bladder | Incontinence, Urinary and Urinary Bladder, OveractiveUnited States, Canada
-
Far Eastern Memorial HospitalRecruitingFemale Patients With Overactive Bladder SyndromeTaiwan
-
Northwestern UniversityUniversity of Alberta; Ohio State University; University of CalgaryRecruitingUrologic Diseases | Overactive Bladder | Urinary Incontinence | Overactive Bladder SyndromeUnited States
-
PfizerCompletedOveractive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary IncontinenceUnited States
-
Pierre and Marie Curie UniversityCompleted
-
Loyola UniversityCompletedOveractive BladderUnited States
-
Isra UniversityUnknown
-
Velicept Therapeutics, Inc.Completed
-
R-PharmSynergy Research Inc.CompletedOveractive BladderRussian Federation
-
The Hospital of VestfoldSouth-Eastern Norway Regional Health AuthorityCompletedOveractive BladderNorway
-
Mansoura UniversityUnknownOveractive Bladder | Botulinum Toxin | ESWL | IntravesicalEgypt
-
SanofiCompletedOveractive BladderFrance, Germany, Netherlands, Portugal, Czech Republic, United States, Canada
-
Astellas Pharma IncCompletedOveractive Bladder | Cardiovascular DiseaseJapan
-
Assistance Publique - Hôpitaux de ParisCompletedOveractive BladderFrance
-
Kissei Pharmaceutical Co., Ltd.Completed
-
Kissei Pharmaceutical Co., Ltd.WithdrawnOveractive BladderJapan
-
Watson PharmaceuticalsCompleted
-
Medstar Health Research InstituteUniversity of Oklahoma; University of Texas; Indiana UniversityCompletedOveractive Bladder | Female Sexual DysfunctionUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedProstate AdenocarcinomaUnited States
-
Astellas Pharma IncTerminatedBladder FunctionUnited States
-
Western Galilee Hospital-NahariyaCompletedPost Operative Complications | Intra-operative ComplicationsIsrael
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingUrinary Incontinence | Overactive Bladder SyndromeUnited States
-
University of AlbertaWomen and Children's Health Research Institute, CanadaRecruitingPostoperative Urinary Tract Infection | Idiopathic Overactive BladderCanada
-
Hisar Intercontinental HospitalCompleted
-
Aristotle University Of ThessalonikiRecruiting
-
Urovant Sciences GmbHCompleted
-
Biruni UniversityCompletedOveractive Bladder
-
Women and Infants Hospital of Rhode IslandCompletedOveractive Bladder
-
Liverpool Women's NHS Foundation TrustManchester Metropolitan UniversityCompletedOveractive BladderUnited Kingdom
-
University of PennsylvaniaPfizerCompletedOveractive BladderUnited States
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
AllerganCompletedOveractive BladderCanada, United States
-
PfizerCompletedOveractive BladderUnited States
-
Lee's Pharmaceutical LimitedAPOGEPHA Arzneimittel GmbHCompleted
-
Maastricht University Medical CenterScientific Foundation Urology MaastrichtCompleted
-
Cairo UniversityRecruiting
-
Ludwig-Maximilians - University of MunichRecruitingOveractive Bladder | Lower Urinary Tract Symptoms | Chemotherapy Effect | Chemotherapeutic ToxicityGermany
-
Campbell GrantTerminatedOveractive BladderUnited States
-
Urological Sciences Research FoundationAllerganUnknownOveractive BladderUnited States
-
BayerCompletedOveractive BladderAustria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Latvia, Hungary, Canada, Lithuania, Poland
-
Velicept Therapeutics, Inc.CompletedOveractive BladderUnited States
-
Merck Sharp & Dohme LLCCompleted
-
PfizerCompleted